Calculate Allergan BIOCELL recall settlements. BIA-ALCL cancer, explant surgery compensation claims.
Calculate SettlementJuly 24, 2019
Recall Date
400,000+
Implanted
1,100+
ALCL Cases
Class I
FDA Recall
Breast implant-associated lymphoma
$400,000
projected value
Removed recalled implants
$75,000
projected value
Capsular contracture, rupture
$100,000
projected value
In July 2019, the FDA issued the first-ever breast implant recall in U.S. history. Allergan voluntarily recalled all BIOCELL textured breast implants and tissue expanders due to the risk of BIA-ALCL.
BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is a rare cancer linked specifically to textured implants. Over 1,100 cases have been reported worldwide, with 60+ deaths.
Free calculator for Allergan recall victims.
Start Free Calculator